Literature DB >> 9092112

Transanal endoscopic microsurgery.

T J Saclarides1.   

Abstract

Traditional methods of excising adenomas and selected carcinomas of the distal rectum provide adequate exposure and acceptable cure rates. Recurrence rates after locally excising adenomas, however, are 12% to 25%, possibly because the limited exposure has led to less than adequate resection margins. Whether or not TEM can yield lower recurrence rates remains to be seen, but this perhaps is not the main reason one should include TEM in his or her armamentarium. Rather, it is the improved exposure, the superior optics, and the opportunity to address lesions in the upper rectum that set TEM apart from conventional instrumentation. One should also keep in mind that these "inaccessible" lesions have been treated heretofore with either a transsacral or transabdominal approach, both of which are accompanied by a lengthy hospital stay and potential morbidity. When considering TEM excision of rectal cancers, proper patient selection cannot be overemphasized. Endorectal ultrasonography can help to determine depth of penetration preoperatively, and TEM can be used with curative intent for those lesions with minimal involvement of the rectal wall. TEM can also be used as a means to palliate the primary tumor of those patients with incurable, disseminated disease. Minimal-access surgery is here to stay. TEM may gain acceptance in this arena, marking a new technology for the treatment of a number of rectal conditions. The considerable skill necessary to perform this operation, combined with the relatively infrequent nature of the pathology addressed, however, will make TEM the domain of only a few surgeons.

Entities:  

Mesh:

Year:  1997        PMID: 9092112     DOI: 10.1016/s0039-6109(05)70541-7

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  8 in total

1.  UltraCision or high-frequency knife in transanal endoscopic microsurgery (TEM)? Advantages of a new procedure.

Authors:  C Langer; P Markus; T Liersch; L Füzesi; H Becker
Journal:  Surg Endosc       Date:  2001-03-13       Impact factor: 4.584

2.  Transanal endoscopic microsurgery for carcinoma of the rectum.

Authors:  S Maslekar; S H Pillinger; J R T Monson
Journal:  Surg Endosc       Date:  2006-11-16       Impact factor: 4.584

3.  Ten-year experience of endoscopic transanal resection.

Authors:  Christopher D Sutton; Leslie-Jayne Marshall; Steve A White; Neil Flint; David P Berry; Michael J Kelly
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

4.  Giant adenomas of the rectum: complete resection by transanal endoscopic microsurgery (TEM).

Authors:  Hartmut Schäfer; Stefan E Baldus; Arnulf H Hölscher
Journal:  Int J Colorectal Dis       Date:  2005-08-20       Impact factor: 2.571

5.  Peritoneal perforation during transanal endoscopic microsurgery is not associated with significant short-term complications.

Authors:  Jonathan Ramkumar; Ahmer A Karimuddin; P Terry Phang; Manoj J Raval; Carl J Brown
Journal:  Surg Endosc       Date:  2018-07-18       Impact factor: 4.584

6.  Postoperative complications in the treatment of rectal neoplasia by transanal endoscopic microsurgery: a prospective study of risk factors and time course.

Authors:  Carlos Frederico S Marques; Caio Sergio R Nahas; Ulysses Ribeiro; Leonardo A Bustamante; Rodrigo Ambar Pinto; Eduardo Kenzo Mory; Ivan Cecconello; Sergio Carlos Nahas
Journal:  Int J Colorectal Dis       Date:  2016-02-09       Impact factor: 2.571

7.  Gasless, video endoscopic transanal excision for carcinoid and laterally spreading tumors of the rectum.

Authors:  T Nakagoe; H Ishikawa; T Sawai; T Tsuji; M Jibiki; A Nanashima; H Yamaguchi; T Yasutake
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

8.  Mapping the rectum: spatial analysis of transanal endoscopic microsurgical outcomes using GIS technology.

Authors:  Sabha Ganai; Jane L Garb; Prathima Kanumuri; Roshni S Rao; Albert I Alexander; Richard B Wait
Journal:  J Gastrointest Surg       Date:  2006-01       Impact factor: 3.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.